| ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
|---|---|---|---|---|---|---|
| CP001131 |
|
80433-71-2 |
CALCIUM LEVOFOLINATE - 99% |
0 | C20H21CAN7O7 | |
| CP007665 |
|
3083-77-0 |
1-((2R,3S,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione - 98.0% |
0 | C9H12N2O6 | |
| CP004030 |
|
69-74-9 |
cytosine arabinoside hydrochloride - 99% |
0 | C9H13N3O5.HCL | |
| CP006671 |
|
83480-29-9 |
Voglibose - 98.0%~102.0% |
0 | C10H21NO7 | |
| CP004794 |
|
51627-14-6 |
CEFATRIZINE PROPYLENE GLYCOL - 98% |
0 | C18H18N6O5S2 | |
| CP008469 |
|
1320-66-7 |
Chlorobutanol - 99% |
0 | C4H9CLO | |
| CP008406 |
|
124832-27-5 |
Valacyclovir hydrochloride - 98% |
0 | C13H21CLN6O4 | |
| CP008297 |
|
41136-22-5 |
ceftezole sodium - 90% |
0 | C13H11N8NAO4S3 | |
| CP005865 |
|
411235-57-9 |
Cyclopropylboronic acid - 98% |
0 | C3H7BO2 | |
| CP002756 |
|
83-46-5 |
beta-Sitosterol - ≥95% |
0 | C29H50O | |
| CP003512 |
|
107-97-1 |
Sarcosine - 98% |
0 | C3H7NO2 | |
| CP002697 |
|
57808-65-8 |
N-(5-Chloro-4-((4-chlorophenyl)(cyano)methyl)-2-methylphenyl)-2-hydroxy-3,5-diiodobenzamide - 97.0-103.0% |
0 | C22H14N2O2CL2I2 | |
| CP005784 |
|
69-89-6 |
2,6-Dihydroxypurine - 98-102%(UV) |
0 | C5H4N4O2 | |
| CP006303 |
|
58-86-6 |
N/A - 99% |
0 | C5H10O5 | |
| CP004903 |
|
120709-09-3 |
(6R,7R)-7-Amino-8-oxo-3-(prop-1-en-1-yl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid - 98% |
0 | C10H12N2O3S | |
| CP007434 |
|
63610-08-2 |
Indobufen - 98% |
0 | C18H17NO3 | |
| CP001290 |
|
247257-48-3 |
2-(1-((2'-(2H-Tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-2-butyl-4-methyl-6-oxo-1,6-dihydropyrimidin-5-yl)-N,N-dimethylethanethioamide - 99%-101.0% |
0 | C27H31N7OS | |
| CP007560 |
|
152044-53-6 |
Epothilone A - 98% |
0 | C26H39NO6S | |
| CP004636 |
|
24701-69-7 |
7-Amino-3-methoxymethyl-3-cephem-4-carboxylic acid - 96% |
0 | C9H12N2O4S | |
| CP000381 |
|
21193-75-9 |
D-Galactal - 98% |
0 | C6H10O4 | |